BW gain is probably a benefit in purely insulin-deficient patients in whom lack of insulin is responsible for lean tissue loss [4], but in T2D the worsening of existing obesity seems undesirable. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.